Earl Douglas's Insider Trades & SAST Disclosures

Earl Douglas's most recent trade in Allogene Therapeutics Inc was a trade of 6,404 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on Feb. 3, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Allogene Therapeutics Inc
Earl Douglas SVP, General Counsel Sale of securities on an exchange or to another person at price $ 1.71 per share. 03 Feb 2025 6,404 587,848 (0%) 0% 1.7 10,951 Common Stock
Allogene Therapeutics Inc
Earl Douglas SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2025 512,370 512,370 - - Stock Option (Right to buy)
Allogene Therapeutics Inc
Earl Douglas SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2025 144,928 594,252 (0%) 0% 0 Common Stock
Allogene Therapeutics Inc
Earl Douglas SVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.78 per share. 21 Aug 2024 28,310 449,324 (0%) 0% 2.8 78,843 Common Stock
Allogene Therapeutics Inc
Earl Douglas SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 147,778 147,778 - - Stock Option (Right to buy)
Allogene Therapeutics Inc
Earl Douglas SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 41,800 477,634 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades